Underlying

EX-10.36 4 dex1036.htm LETTER AGREEMENT DATED OCTOBER 31, 2005 Letter Agreement dated October 31, 2005

Exhibit 10.36

October 31, 2005

Mr. David Grin

Laurus Master Fund, Ltd.

c/o Laurus Capital Management, LLC

825 Third Avenue 14th Fl.

New York, NY 10022

 

RE: Exercise Price of Laurus Warrants

Dear Mr. Grin:

On October 31, 2005, we closed the sale of the following securities to institutional investors: (i) 14,925,743 shares of the Company’s common stock, plus (ii) five-year, non-callable warrants to purchase another 5,970,297 shares of common stock with an exercise price of $1.20 per share (the “Offering”). The aggregate purchase price for the securities sold in the Offering was $1.01 per share of common stock initially being sold or $15,075,000. In conjunction therewith, we have repaid all indebtedness (including interest, prepayment fees and other fees) to Laurus and agree that the Exercise Price (as defined in the warrants) of the warrants owned by Laurus Master Fund, Ltd. reset as follows:

 

Warrant Owner

   Issue
Year
   Expiration
Year
  

Underlying

Shares

   Exercise Price
            Old    New

Laurus Master Fund, Ltd

   2003    2010    200,000    $ 2.25    $ 1.92

Laurus Master Fund, Ltd

   2003    2010    200,000    $ 2.44    $ 2.07

Laurus Master Fund, Ltd

   2003    2010    150,000    $ 2.82    $ 2.35

Laurus Master Fund, Ltd

   2004    2011    125,000    $ 3.11    $ 2.57

Laurus Master Fund, Ltd

   2004    2011    400,000    $ 1.25    $ 1.18
                
         1,075,000      

Sincerely,

 

TRANSGENOMIC, INC.
By:  

/s/ Michael A. Summers

  Michael A. Summers
  Chief Financial Officer

Agreed and accepted on the date hereof

 

LAURUS MASTER FUND, LTD.

By:  

/s/ David Grin

  David Grin
  Director